Lv21
120 积分 2026-09-19 加入
MAGI3 deficiency unleashes β-catenin conformational change to drive metastatic progression and mTOR inhibitor resistance in ccRCC
24天前
已完结
Administration of nivolumab plus ipilimumab: Infusion of the fixed‐ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800)
26天前
已完结
First and Second-line Treatments in Metastatic Renal Cell Carcinoma
26天前
已完结
Prognostic Impact of the Maximal Evaluable Lesion Size in Patients With Metastatic Renal Cell Carcinoma Treated With Nivolumab Plus Ipilimumab Combination Therapy
26天前
已完结
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
26天前
已完结
MAGI3 deficiency unleashes β-catenin conformational change to drive metastatic progression and mTOR inhibitor resistance in ccRCC
29天前
已完结
Astragalus polysaccharide enhances the antitumor efficacy of sunitinib in renal cell carcinoma by targeting the ZEB1-SCD1-Wnt/β-Catenin signaling pathway
30天前
已完结
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma
1个月前
已完结
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
1个月前
已完结
Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study
1个月前
已完结
皖公网安备34019202002308
